163 related articles for article (PubMed ID: 21052675)
1. Serum levels of soluble CD21 in patients with systemic sclerosis.
Tomita M; Kadono T; Yazawa N; Kawashima T; Tamaki Z; Ashida R; Ohmatsu H; Asano Y; Sugaya M; Kubo M; Ihn H; Tamaki K; Sato S
Rheumatol Int; 2012 Feb; 32(2):317-21. PubMed ID: 21052675
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
Masilamani M; von Kempis J; Illges H
Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
[TBL] [Abstract][Full Text] [Related]
3. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
[TBL] [Abstract][Full Text] [Related]
5. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
Front Immunol; 2021; 12():686483. PubMed ID: 34276673
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation.
Masilamani M; Apell HJ; Illges H
J Immunol Methods; 2002 Dec; 270(1):11-8. PubMed ID: 12379334
[TBL] [Abstract][Full Text] [Related]
7. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble carbonic anhydrase IX are decreased in patients with diffuse cutaneous systemic sclerosis compared to those with limited cutaneous systemic sclerosis.
Makino K; Jinnin M; Makino T; Kajihara I; Fukushima S; Inoue Y; Ihn H
Biosci Trends; 2014 Jun; 8(3):144-8. PubMed ID: 25030848
[TBL] [Abstract][Full Text] [Related]
9. Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.
Masilamani M; Rajasekaran N; Singh A; Low HZ; Albus K; Anders S; Behne F; Eiermann P; König K; Mindnich C; Ribarska T; Illges H
Rheumatol Int; 2008 Sep; 28(11):1137-41. PubMed ID: 18500464
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD21 in sera and synovial fluid of arthritic patients.
Grottenthaler T; von Kempis J; Goldacker S; Illges H
Rheumatol Int; 2006 Jan; 26(3):240-3. PubMed ID: 15770483
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis.
Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
[TBL] [Abstract][Full Text] [Related]
13. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
[TBL] [Abstract][Full Text] [Related]
14. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
Singh A; Vastert SJ; Prakken BJ; Illges H
Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.
Corrado A; Colia R; Mele A; Di Bello V; Trotta A; Neve A; Cantatore FP
PLoS One; 2015; 10(9):e0137912. PubMed ID: 26375284
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
[TBL] [Abstract][Full Text] [Related]
17. Downregulated IRF8 in Monocytes and Macrophages of Patients with Systemic Sclerosis May Aggravate the Fibrotic Phenotype.
Ototake Y; Yamaguchi Y; Asami M; Komitsu N; Akita A; Watanabe T; Kanaoka M; Kurotaki D; Tamura T; Aihara M
J Invest Dermatol; 2021 Aug; 141(8):1954-1963. PubMed ID: 33705797
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of anti-Fcγ receptor IIB/C antibodies are increased in patients with systemic sclerosis.
Kadono T; Tomita M; Tamaki Z; Sato S; Asano Y
J Dermatol; 2014 Nov; 41(11):1009-12. PubMed ID: 25346304
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
[TBL] [Abstract][Full Text] [Related]
20. Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.
Cossu M; van Bon L; Preti C; Rossato M; Beretta L; Radstake TRDJ
Arthritis Rheumatol; 2017 Dec; 69(12):2359-2369. PubMed ID: 28859262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
